DRACEN PHARMACEUTICALS, INC.

Profile

Company Names

DRACEN PHARMACEUTICALS, INC.

Addresses

9276 SCRANTON ROAD #200, SAN DIEGO, CA 92121

780 THIRD AVE., 18TH FLOOR, NEW YORK, NY 10017

C/O HOGAN LOVELLS US LLP, 100 INTERNATIONAL DRIVE, SUITE 2000, BALTIMORE, MD 21202

Phone Numbers

410-659-2777

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2016

State Incorporated:

DELAWARE

Total Amount Raised:

$19,358,294.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2023-06-11 
$2,285,000.00 
$2,785,000.00 
$500,000.00 
Debt 
2
2021-11-01 
$8,584,398.00 
$17,046,698.00 
$8,462,300.00 
Equity 
1
2018-01-11 
$8,488,896.00 
$40,489,688.00 
$32,000,792.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DENNIS 
 
BILSKI 
EXECUTIVE OFFICER
TRAGARA PHARMACEUTICALS, INC.   |  DRACEN PHARMACEUTICALS, INC.
DENNIS 
M. 
BILSKI 
EXECUTIVE OFFICER
DRACEN PHARMACEUTICALS, INC.
THOMAS 
M. 
ESTOK 
EXECUTIVE OFFICER, DIRECTOR
TRAGARA PHARMACEUTICALS INC   |  AARDEN PHARMACEUTICALS, INC.   |  TRAGARA PHARMACEUTICALS, INC.   |  DRACEN PHARMACEUTICALS, INC.   |  ADASTRA PHARMACEUTICALS, INC.
ROBERT 
 
JACKSON 
DIRECTOR
FLEMISH GOLD CORP.   |  DRACEN PHARMACEUTICALS, INC.   |  VIBLIOME THERAPEUTICS, LLC   |  NUVALENT, INC.   |  PERCEIVE BIOTHERAPEUTICS, INC.   |  CREDHUB, INC.
JONATHAN 
 
LEFF 
DIRECTOR
HANA BIOSCIENCES INC   |  RIB X PHARMACEUTICALS INC   |  TALON THERAPEUTICS, INC.   |  N30 PHARMACEUTICALS, INC.   |  AUDENTES THERAPEUTICS, INC.   |  AVEXIS, INC.   |  APRECIA PHARMACEUTICALS CO   |  PROTEON THERAPEUTICS INC   |  DRACEN PHARMACEUTICALS, INC.   |  ARS PHARMACEUTICALS, INC.   |  MIRUM PHARMACEUTICALS, INC.   |  CHONDRIAL THERAPEUTICS HOLDINGS, LLC   |  LARIMAR THERAPEUTICS, INC.   |  AVALYN PHARMA INC.   |  AEROVATE THERAPEUTICS, INC.   |  ADAPTIVE PHAGE THERAPEUTICS, INC.   |  INNERVACE, INC.   |  BIOMX INC.   |  ELION THERAPEUTICS, INC.   |  AXONIS THERAPEUTICS, INC.
DREW 
 
PARDOLL, M.D., PH.D. 
DIRECTOR
DRACEN PHARMACEUTICALS, INC.
ASHER 
 
RUBIN 
EXECUTIVE OFFICER
BIG RED SOCIAL CORP.   |  NEXTCURE, INC.   |  DRACEN PHARMACEUTICALS, INC.   |  TAMUROBIO INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-08-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2023-06-11 
2021-11-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-11-01 
2018-01-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-01-11 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#